Arthur Daemmrich is the director of the Lemelson Center for the Study of Invention and Innovation at the Smithsonian Institution. Located in the National Museum of American History, the Lemelson Center’s staff and visiting scholars analyze invention and innovation, create educational programs to inspire the next generation of inventors, and design exhibits that engage museum visitors. Daemmrich’s research explores relationships between regulation and innovation through historical and comparative studies of the pharmaceutical industry, the chemicals sector, and healthcare systems. He is the author of Pharmacopolitics: Drug Regulation in the United States and Germany and has published over 25 peer-reviewed journal articles and book chapters in science and technology studies, the history of science, technology and medicine, and health and business policy, as well as numerous teaching cases and notes. Daemmrich previously was an associate professor at the University of Kansas School of Medicine, assistant professor at Harvard Business School, a visiting professor at the China Europe International Business School, and the director of the Center for Contemporary History and Policy at the Chemical Heritage Foundation. He holds a Ph.D. from Cornell University in Science and Technology Studies and a B.A. from the University of Pennsylvania in the History and Sociology of Science.